目錄:杭州斯達(dá)特生物科技有限公司>>蛋白>>藥物靶點(diǎn)和Fc受體>> UA010907TSLPR Fc Chimera Protein, Human
參考價(jià) | ¥ 1280 |
參考價(jià) | ¥ 1280 |
更新時(shí)間:2025-06-17 10:09:25瀏覽次數(shù):21評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,,謝謝!
The TSLP receptor (TSLPR, also known as CRLM-2) is a heterodimeric cytokine receptor composed of a TSLP-binding subunit (TSLPRα) and the α-subunit of the IL-7 receptor (IL-7Rα). TSLPR mRNA is expressed in various immune cell types, including dendritic cells (DCs), T cells, B cells, mast cells, NKT cells, and monocytes, as well as in tissues such as the heart, skeletal muscle, kidney, and liver. While TSLPR has a low affinity for TSLP, it forms a high-affinity binding site for TSLP when combined with IL-7Rα, thereby initiating signaling. The TSLPR regulates target gene expression through the JAK/STAT signaling pathway, involving signal transducers and activators of transcription STAT3, STAT5, and STAT1. Genetic, experimental, and clinical evidence indicates that the TSLP-TSLPR pathway is implicated in the pathogenesis of allergic diseases, including atopic dermatitis (AD) and asthma.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)